BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9229719)

  • 1. [Isolation and receptor binding properties of alkaloids and lignans from Valeriana officialis L].
    Bodesheim U; Hölzl J
    Pharmazie; 1997 May; 52(5):386-91. PubMed ID: 9229719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chelidonium majus L.: components with in vitro affinity for the GABAA receptor. Positive cooperation of alkaloids.
    Häberlein H; Tschiersch KP; Boonen G; Hiller KO
    Planta Med; 1996 Jun; 62(3):227-31. PubMed ID: 8693034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New lignans from the roots of Valeriana prionophylla with antioxidative and vasorelaxant activities.
    Piccinelli AL; Arana S; Caceres A; di Villa Bianca Rd; Sorrentino R; Rastrelli L
    J Nat Prod; 2004 Jul; 67(7):1135-40. PubMed ID: 15270567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
    Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
    Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABA(A) receptors, from Valeriana wallichii.
    Wasowski C; Marder M; Viola H; Medina JH; Paladini AC
    Planta Med; 2002 Oct; 68(10):934-6. PubMed ID: 12391561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two flavones from Scutellaria baicalensis Georgi and their binding affinities to the benzodiazepine site of the GABAA receptor complex.
    Wang H; Hui KM; Xu S; Chen Y; Wong JT; Xue H
    Pharmazie; 2002 Dec; 57(12):857-8. PubMed ID: 12561253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of brain receptor binding inhibition by endogenous macromolecular substances [proceedings].
    Van Gompel P; Leysen JE
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B51-B53. PubMed ID: 6155859
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies.
    Deecher DC; Teitler M; Soderlund DM; Bornmann WG; Kuehne ME; Glick SD
    Brain Res; 1992 Feb; 571(2):242-7. PubMed ID: 1377086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secophnane-type alkaloids from Daphniphyllum oldhami.
    Mu SZ; Yang XW; Di YT; He HP; Wang Y; Wang YH; Li L; Hao XJ
    Chem Biodivers; 2007 Feb; 4(2):129-38. PubMed ID: 17311225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkaloids with human delta-opioid receptor binding affinity from the Australian rainforest tree Peripentadenia mearsii.
    Katavic PL; Venables DA; Guymer GP; Forster PI; Carroll AR
    J Nat Prod; 2007 Dec; 70(12):1946-50. PubMed ID: 18039010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential stereoselectivity of methotrimeprazine enantiomers for selected central nervous system receptor types.
    Robert TA; Hagardorn AN; Daigneault EA
    Mol Pharmacol; 1982 Mar; 21(2):315-9. PubMed ID: 6285167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive cooperation of protoberberine type 2 alkaloids from Corydalis cava on the GABA(A) binding site.
    Halbsguth C; Meissner O; Häberlein H
    Planta Med; 2003 Apr; 69(4):305-9. PubMed ID: 12709895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norditerpenoid alkaloids from the roots of Aconitum leave Royle.
    Ulubelen A; Meriçli AH; Meriçli F; Kolak U; Arfan M; Ahmad M; Ahmad H
    Pharmazie; 2002 Jun; 57(6):427-9. PubMed ID: 12116884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
    Johansson PA; Andersson M; Andersson KE; Cenci MA
    Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors.
    Schumacher B; Scholle S; Hölzl J; Khudeir N; Hess S; Müller CE
    J Nat Prod; 2002 Oct; 65(10):1479-85. PubMed ID: 12398547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indolizidine alkaloids with delta-opioid receptor binding affinity from the leaves of Elaeocarpus fuscoides.
    Katavic PL; Venables DA; Rali T; Carroll AR
    J Nat Prod; 2007 May; 70(5):872-5. PubMed ID: 17451272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA and opioid binding distribution in the brain of the seizure-resistant Proechimys guyannensis: an autoradiography study.
    Rocha L; Arida RM; Carvalho Rde A; Scorza FA; Neri-Bazan L; Cavalheiro EA
    Synapse; 2006 Oct; 60(5):392-8. PubMed ID: 16847947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency stimulation modifies receptor binding in rat brain.
    López-Meraz ML; Neri-Bazán L; Rocha L
    Epilepsy Res; 2004; 59(2-3):95-105. PubMed ID: 15246114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The action of some tetrahydroisoquinoline alkaloids on dopamine and serotonin receptors in the rat brain].
    Chen SG; Liu GQ; Min ZD
    Yao Xue Xue Bao; 1987 May; 22(5):341-6. PubMed ID: 3687458
    [No Abstract]   [Full Text] [Related]  

  • 20. Binding studies for serotoninergic, dopaminergic and noradrenergic receptors of Valeriana adscendens Trel. extracts.
    Nencini C; Cavallo F; Capasso A; De Feo V; De Martino L; Bruni G; Giorgi G; Micheli L
    J Ethnopharmacol; 2006 Nov; 108(2):185-7. PubMed ID: 16839726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.